High-Content Profiling of Drug-Drug Interactions: Cellular Targets Involved in the Modulation of Microtubule Drug Action by the Antifungal Ketoconazole
Open Access
- 1 April 2003
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 8 (2) , 125-135
- https://doi.org/10.1177/1087057103252616
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Interaction of Cytochrome P450 3A Inhibitors with P-GlycoproteinThe Journal of Pharmacology and Experimental Therapeutics, 2002
- MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cellsCellular Signalling, 2001
- The Role of ERK 1/2 and p38 MAP-Kinase Pathways in Taxol-Induced Apoptosis in Human Ovarian Carcinoma CellsExperimental Cell Research, 2001
- Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2Journal of Biological Chemistry, 2000
- Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cellsOncogene, 1999
- High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery ProcessSLAS Discovery, 1997
- In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3Cancer Letters, 1997
- Clinical Pharmacokinetics of KetoconazoleClinical Pharmacokinetics, 1988
- Hepatic toxicity of ketoconazoleBritish Journal of Dermatology, 1983
- Ketoconazole — a new broad spectrum orally active antimycoticCellular and Molecular Life Sciences, 1979